https://www.selleckchem.com/products/erastin.html
3%, 95% CI, 31.1-72.6%; culture 60.9%, 95% CI, 38.8-79.5%). In clinical TB cases, mNGS detected additional positive results (40.6%, 26/64). mNGS reduced the turnaround time from 2-6 weeks to 32-36 hours. mNGS may be a promising technology for the early auxiliary diagnosis of active TB, especially sputum-negative pulmonary TB (PT and tuberculous serous effusion. mNGS may be a promising technology for the early auxiliary diagnosis of active TB, especially sputum-negative pulmonary TB (PT and tuberculous serous effusion. Pathological c
Like
Comment
Share
